Cerebral resuscitation with succinate and fructose-1, 6-diphosphate.
To test the hypotheses that succinate or fructose-1, 6-diphosphate may have a beneficial effect in global cerebral ischemia, we induced complete global cerebral ischemia for 5 minutes in rabbits by occlusion of the ascending aorta and the superior and inferior vena cavae. Fifteen minutes after restoration of cerebral blood flow, animals received an intravenous bolus of either succinate or fructose-1,6-diphosphate followed by continuous infusion. Another group of animals received fructose-1, 6-diphosphate beginning prior to aortic occlusion. Control animals received intravenous glucose by bolus, followed by infusion. Cerebrospinal fluid lactate levels were measured before occlusion and at 2 1/2 hours after occlusion, when the animals were sacrificed. In all animals electrocortical silence was demonstrated for the 5 minutes of global ischemia. The percent change in cerebrospinal fluid lactate levels in all groups was statistically similar. Only two of seven of the control animals recovered electroencephalogram amplitude during the 2 1/2 hour observation period. Time for recovery of amplitude on the electroencephalogram in animals receiving fructose-1, 6-diphosphate either before or after ischemia was statistically similar to controls. In the succinate treated group, all seven animals regained preocclusion levels of electroencephalogram amplitude within 36 minutes of the restoration of cerebral blood flow. Succinate administered after complete global cerebral ischemia resulted in significantly increased recovery of cerebral electrical activity (Fischer's exact test, p less than 0.05).
Cannella
D M
DM
Department of Neurosurgery, SUNY-Buffalo 14203.
Kapp
J P
JP
Munschauer
F E
FE
Markov
A K
AK
Shucard
D W
DW
D000818:Animals; D002545:Brain Ischemia / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000503:physiopathology*; D002560:Cerebrovascular Circulation; D004569:Electroencephalography; D005635:Fructosediphosphates / Q000008:administration & dosage / Q000627:therapeutic use*; D006598:Hexosediphosphates / Q000627:therapeutic use*; D007773:Lactates / Q000134:cerebrospinal fluid; D011817:Rabbits; D015424:Reperfusion; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use*; D019802:Succinic Acid
D005635:Fructosediphosphates; D006598:Hexosediphosphates; D007773:Lactates; D013386:Succinates; D019802:Succinic Acid; C029063:fructose-1,6-diphosphate